Banco Santander’s Jazz Pharmaceuticals JAZZ Stock Holding History

Banco Santander’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-8,804	Closed	-$1.66M	–	533
2026 Q1	$1.66M	Buy	+8,804	New	+$1.54M	0.01%	284

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Banco Santander's JAZZ Position: Q2 2026 in Review

Banco Santander sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2026, closing a stake of 8,804 shares — an estimated $1.66M sold.

Banco Santander first reported a position in JAZZ in Q1 2026 and held it in 1 quarter. The position peaked at $1.66M in Q1 2026. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

Banco Santander reported no remaining Jazz Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Banco Santander sold 8,804 Jazz Pharmaceuticals shares in Q2 2026, an estimated $1.66M.
Banco Santander first reported a position in Jazz Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Banco Santander's Jazz Pharmaceuticals position peaked at $1.66M in Q1 2026.
646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Banco Santander's 13F filing for Q2 2026, filed 29 Jul 2026.